Liminatus Pharma, Inc. Class A Common Stock (LIMN)

NASDAQ: LIMN • USD
0.18 USD
+0.01 (+6.21%)
AT CLOSE (11:59 AM EDT)
0.18
+0.00 (+1.71%)
POST MARKET (AS OF 07:49 PM EDT)
🔴Market: CLOSED
Open?$0.17
High?$0.19
Low?$0.16
Prev. Close?$0.18
Volume?510.5K
Avg. Volume?N/A
VWAP?$0.17
Bid / Ask
Bid?$0.16 × 5.0K
Ask?$0.97 × 2.6K
Spread?$0.81
Midpoint?$0.56
Valuation & Ratios
Market Cap?6.9M
Shares Out?31.1M
Float?5.3M
Float %?20.5%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Related Companies
Loading...
News
Profile
Liminatus Pharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing cancer therapies and treatments. The GCC Vaccine of the company is in Phase II of clinical trials designed for immune behavior towards colorectal, pancreatic, gastric, and esophageal cancers that express Guanylyl Cyclase C.
Employees
N/A
Market Cap
6.9M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
N/A
Listed
2025-05-01
Address
12611 HIDDENCREEK WAY
CERRITOS, CA 90703
Phone: 213-273-5453
MarketsMoversWatchlist